6 Sources
[1]
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024 By Investing.com
NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: NASDAQ:ICAD) (iCAD or the Company) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the
[2]
SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products - SKYX Platforms (NASDAQ:SKYX)
MIAMI, Aug. 12, 2024 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. SKYX (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and
[3]
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Acrivon Therapeutics (NASDAQ:ACRV)
WATERTOWN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") ACRV, a clinical stage precision medicine company utilizing its Acrivon Precision Predictive Proteomics (AP3) platform for the discovery, design, and development of drug candidates
[4]
Janover Reports Second Quarter 2024 Financial Results and Provides Business Update - Janover (NASDAQ:JNVR)
With Another Quarter of Sequential Revenue Growth Achieved a Record 20% of Total Revenue from Recurring and Subscription Revenue BOCA RATON, Fla., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Janover Inc. JNVR ("Janover" or the "Company"), an AI-enabled platform for commercial real estate transactions,
[5]
SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Sma By Investing.com
MIAMI, Aug. 12, 2024 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the Company or SKYX), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes
[6]
Spectral AI Announces 2024 Second Quarter Financial Results - Spectral AI (NASDAQ:MDAIW), Spectral AI (NASDAQ:MDAI)
Second Quarter Revenue Totals $7.5 Million Total Enrollment Exceeds 85% for Burn Center Pivotal U.S. Clinical Trial Q2 2024 Overview Research & Development Revenue of $7.5 MillionCash Position of $6.9 MillionOn Track to Generate First Commercial Revenues in the U.K. Later this YearBurn Pivotal
Share
Copy Link
Several companies, including iCAD, SKYX, Acrivon Therapeutics, and Janover, have reported their second quarter 2024 financial results. While some companies showed growth, others faced challenges in revenue and net losses.

iCAD, Inc., a global medical technology leader, announced its financial results for the second quarter ended June 30, 2024. The company reported total revenue of $5.5 million, a decrease from $7.6 million in the same period last year. Despite the revenue decline, iCAD's net loss improved to $1.9 million, compared to $3.1 million in Q2 2023
1
.SKYX Platforms Corp. reported impressive second-quarter results, with record sales of $21.4 million, a significant increase from $15.0 million in the same quarter of 2023. This growth represents a 42.7% year-over-year increase. The company's gross profit also saw a substantial rise, reaching $7.0 million compared to $4.8 million in Q2 2023
2
.Acrivon Therapeutics, Inc. released its second quarter 2024 financial results and provided updates on its business operations. The company reported a net loss of $17.9 million for the quarter. As of June 30, 2024, Acrivon had cash, cash equivalents, and marketable securities totaling $159.1 million, which is expected to fund operations into 2026
3
.Janover Inc. announced its financial results for the second quarter of 2024 and provided a business update. The company reported total revenue of $463,000 for Q2 2024, a slight decrease from $466,000 in Q2 2023. However, Janover's gross profit increased to $463,000 from $442,000 in the same period last year. The company also highlighted its continued focus on expanding its fintech platform and enhancing user experience
4
.Related Stories
In addition to its record sales, SKYX Platforms Corp. emphasized its growing market penetration in the United States and Canada. The company's advanced smart home technologies and safety-driven electrical products have been gaining traction in these markets. SKYX's innovative solutions, including its smart home and smart building platforms, have contributed to its strong performance in Q2 2024
5
.The Q2 2024 results reveal a mixed picture across different sectors. While companies like SKYX are experiencing significant growth, others such as iCAD and Janover face challenges in maintaining or increasing their revenues. The healthcare and technology sectors continue to show resilience, with companies like Acrivon Therapeutics making progress in their product pipelines despite financial losses. As the market evolves, companies are focusing on innovation, market expansion, and operational efficiency to navigate the competitive landscape and position themselves for future growth.
Summarized by
Navi
[1]
[4]
1
Science and Research

2
Technology

3
Policy and Regulation
